Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence

The impressive results of recent clinical trials with glucagon-like peptide-1 receptor agonists (GLP-1Ra) and sodium glucose transporter 2 inhibitors (SGLT-2i) in terms of cardiovascular protection prompted a huge interest in these agents for heart failure (HF) prevention and treatment. While both c...

Descripción completa

Detalles Bibliográficos
Autores principales: Natali, Andrea, Nesti, Lorenzo, Tricò, Domenico, Ferrannini, Ele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479881/
https://www.ncbi.nlm.nih.gov/pubmed/34583699
http://dx.doi.org/10.1186/s12933-021-01385-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479881/
https://www.ncbi.nlm.nih.gov/pubmed/34583699
http://dx.doi.org/10.1186/s12933-021-01385-5

Ejemplares similares